Integrative Biomedical Research
Volume 10 Number 2 2026
Volume 10 Number 2 2026
Integrative Biomedical Research
Integrative Biomedical Research
Descriptive Table of Contents
Reviews
(Unspecified)
Manuscript-In-Press
Gnanasekaran Ashok 1*, Diksha D Shroff 2, Lubna Shirin 3, Pugazhandhi Bakthavatchalam 4
Oral peptide platforms could finally replace daily insulin/GLP-1 injections, if enzymatic, mucosal, and hepatic barriers are overcome.
Abstract | Full Text | Open Access Article
Manuscript-In-Press
Hashim Abdul-Sattar J. Al-Bajalani 1* Md Sohel Rana 2, Yoghinni Manogaran 3, Ahmed Ahmed Al-Akwaa 4
Engineering extracellular vesicles to cross the blood–brain barrier and escape endosomal trapping could finally make disease-modifying Alzheimer’s therapies deliverable.
Abstract | Full Text | Open Access Article
Manuscript-In-Press
Stimuli-Responsive Nanocarriers Reprogram the Rheumatoid Joint but Outpace Clinical Manufacturing
Ghufran Abd Omran Abdulridha 1,2*, Mustafa Abdulkadhim Hussein 3, Suhad Rasheed Majeed 3 Firas Salih Abdulhadi 4, Ban Talib El-Haboby 4, Jamela Jouda 4
Smart, disease-triggered nanocarriers can concentrate rheumatoid arthritis drugs inside inflamed joints while sparing healthy tissue.
Abstract | Full Text | Open Access Article
Manuscript-In-Press
Targeted Nanomedicine for Triple-Negative Breast Cancer Closing the Delivery Efficiency Gap
Pugazhandhi Bakthavatchalam 1*, Mohammed Shahjahan Kabir 2, Mst Murshida Mahbub 3, Yoghinni Manogaran 4,
Rationally engineered, actively targeted nanocarriers can close the ~0.7% tumor-delivery gap limiting nanomedicine efficacy in triple-negative breast cancer.
Abstract | Full Text | Open Access Article
Manuscript-In-Press
Long Chiau Ming 1*, Ong Khang Wei 2, Nurul Dayana Binti Mahizir 2
Bridging barrier biology, nanomedicine, and physical delivery reveals why glioblastoma therapies still fail to reach infiltrative tumor margins.
Abstract | Full Text | Open Access Article
Molecular & Cellular Biomedicine
Manuscript-In-Press
Fayez Mohammed Hubayni Almutairi 1, Fahad Suliman A Alsaif 1, Saad Abdulrazaq Ahmed Hayjan 1, Mohammed Ahmed Almansour 1, Rana Nashmi Alanazi 1, Khawla Mohammed Abdullah Al-Naim 2*
Mapping compartment-specific ubiquitin-proteasome collapse in Huntington's disease identifies druggable E3 ligase, deubiquitinase, and degrader-based intervention points.
Abstract | Full Text | Open Access Article
Manuscript-In-Press
Cellular Reprogramming Strategies for Age-Related Macular Degeneration From iPSCs to In Vivo Therapy
Andrew Johan 1*, Irene Uli 2, Yosefani Fortunella Yasmine 2
Cellular reprogramming is transforming AMD care from symptom management toward genuine tissue replacement and repair.
Abstract | Full Text | Open Access Article
Submit Article
Use the online submission system to send us your manuscript.
Call For Paper
We are seeking Contributions for a special issue. More.
Best Paper Award
Authors are awarded for Best Paper for this Journal Annually
Advertisement